Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2016-6854
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
An issue was discovered in Open-Xchange OX Guard before 2.4.2-rev5. Script code which got injected to a mail with inline PGP signature gets executed when verifying the signature. Malicious script code can be executed within a user's context. This can lead to session hijacking or triggering unwanted actions via the web interface (sending mail, deleting data etc.).
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Open-Xchange OX Guard 跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Open-Xchange OX Guard是美国Open-Xchange公司的一套针对电子邮件和文件的安全防护软件。 Open-Xchange OX Guard 2.4.2-rev5之前的版本中存在安全漏洞。攻击者可借助特制的邮件利用该漏在用户上下文中执行恶意脚本代码,劫持会话并执行未授权的操作。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2016-6854
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2016-6854
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2016-6854

No comments yet


Leave a comment